These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 22843564)

  • 1. Circulating growth differentiation factor-15 correlates with myocardial fibrosis in patients with non-ischaemic dilated cardiomyopathy and decreases rapidly after left ventricular assist device support.
    Lok SI; Winkens B; Goldschmeding R; van Geffen AJ; Nous FM; van Kuik J; van der Weide P; Klöpping C; Kirkels JH; Lahpor JR; Doevendans PA; de Jonge N; de Weger RA
    Eur J Heart Fail; 2012 Nov; 14(11):1249-56. PubMed ID: 22843564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in myocardial collagen content before and after left ventricular assist device application in dilated cardiomyopathy.
    Liang H; Müller J; Weng YG; Wallukat G; Fu P; Lin HS; Bartel S; Knosalla C; Pregla R; Hetzer R
    Chin Med J (Engl); 2004 Mar; 117(3):401-7. PubMed ID: 15043781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GDF-15 in heart failure: providing insight into end-organ dysfunction and its recovery?
    Wollert KC; Kempf T
    Eur J Heart Fail; 2012 Nov; 14(11):1191-3. PubMed ID: 23047420
    [No Abstract]   [Full Text] [Related]  

  • 4. Prolonged mechanical unloading preserves myocardial contractility but impairs relaxation in rat heart of dilated cardiomyopathy accompanied by myocardial stiffness and apoptosis.
    Muranaka H; Marui A; Tsukashita M; Wang J; Nakano J; Ikeda T; Sakata R
    J Thorac Cardiovasc Surg; 2010 Oct; 140(4):916-22. PubMed ID: 20381089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanical unloading during left ventricular assist device support increases left ventricular collagen cross-linking and myocardial stiffness.
    Klotz S; Foronjy RF; Dickstein ML; Gu A; Garrelds IM; Danser AH; Oz MC; D'Armiento J; Burkhoff D
    Circulation; 2005 Jul; 112(3):364-74. PubMed ID: 15998679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma neurohormone levels correlate with left ventricular functional and morphological improvement in LVAD patients.
    Thompson LO; Skrabal CA; Loebe M; Lafuente JA; Roberts RR; Akgul A; Jones V; Bruckner BA; Thohan V; Noon GP; Youker KA
    J Surg Res; 2005 Jan; 123(1):25-32. PubMed ID: 15652947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Midterm follow-up of patients who underwent removal of a left ventricular assist device after cardiac recovery from end-stage dilated cardiomyopathy.
    Hetzer R; Müller JH; Weng YG; Loebe M; Wallukat G
    J Thorac Cardiovasc Surg; 2000 Nov; 120(5):843-53. PubMed ID: 11044309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial insulin-like growth factor-I gene expression during recovery from heart failure after combined left ventricular assist device and clenbuterol therapy.
    Barton PJ; Felkin LE; Birks EJ; Cullen ME; Banner NR; Grindle S; Hall JL; Miller LW; Yacoub MH
    Circulation; 2005 Aug; 112(9 Suppl):I46-50. PubMed ID: 16159864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteopontin: a potential biomarker for heart failure and reverse remodeling after left ventricular assist device support.
    Schipper ME; Scheenstra MR; van Kuik J; van Wichen DF; van der Weide P; Dullens HF; Lahpor J; de Jonge N; De Weger RA
    J Heart Lung Transplant; 2011 Jul; 30(7):805-10. PubMed ID: 21531579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Who would be a candidate for bridge to recovery during prolonged mechanical left ventricular support in idiopathic dilated cardiomyopathy?
    Matsumiya G; Monta O; Fukushima N; Sawa Y; Funatsu T; Toda K; Matsuda H
    J Thorac Cardiovasc Surg; 2005 Sep; 130(3):699-704. PubMed ID: 16153916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial fibrosis and pro-fibrotic markers in end-stage heart failure patients during continuous-flow left ventricular assist device support.
    Lok SI; Nous FM; van Kuik J; van der Weide P; Winkens B; Kemperman H; Huisman A; Lahpor JR; de Weger RA; de Jonge N
    Eur J Cardiothorac Surg; 2015 Sep; 48(3):407-15. PubMed ID: 25609773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial size and fibrosis changes during left ventricular assist device support.
    Yamada Y; Saito S; Nishinaka T; Yamazaki K
    ASAIO J; 2012; 58(4):402-6. PubMed ID: 22739784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left ventricular assist device support normalizes left and right ventricular beta-adrenergic pathway properties.
    Klotz S; Barbone A; Reiken S; Holmes JW; Naka Y; Oz MC; Marks AR; Burkhoff D
    J Am Coll Cardiol; 2005 Mar; 45(5):668-76. PubMed ID: 15734609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and functional cardiac profile after prolonged duration of mechanical unloading: potential implications for myocardial recovery.
    Castillero E; Ali ZA; Akashi H; Giangreco N; Wang C; Stöhr EJ; Ji R; Zhang X; Kheysin N; Park JS; Hegde S; Patel S; Stein S; Cuenca C; Leung D; Homma S; Tatonetti NP; Topkara VK; Takeda K; Colombo PC; Naka Y; Sweeney HL; Schulze PC; George I
    Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1463-H1476. PubMed ID: 30141986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reverse remodeling of the myocardial extracellular matrix after prolonged left ventricular assist device support follows a biphasic pattern.
    Bruggink AH; van Oosterhout MF; de Jonge N; Ivangh B; van Kuik J; Voorbij RH; Cleutjens JP; Gmelig-Meyling FH; de Weger RA
    J Heart Lung Transplant; 2006 Sep; 25(9):1091-8. PubMed ID: 16962471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain natriuretic peptide is produced both by cardiomyocytes and cells infiltrating the heart in patients with severe heart failure supported by a left ventricular assist device.
    Bruggink AH; de Jonge N; van Oosterhout MF; Van Wichen DF; de Koning E; Lahpor JR; Kemperman H; Gmelig-Meyling FH; de Weger RA
    J Heart Lung Transplant; 2006 Feb; 25(2):174-80. PubMed ID: 16446217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular normalization of dystrophin in the failing left and right ventricle of patients treated with either pulsatile or continuous flow-type ventricular assist devices.
    Vatta M; Stetson SJ; Jimenez S; Entman ML; Noon GP; Bowles NE; Towbin JA; Torre-Amione G
    J Am Coll Cardiol; 2004 Mar; 43(5):811-7. PubMed ID: 14998622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term mechanical unloading and reverse remodeling of failing hearts in children.
    Mohapatra B; Vick GW; Fraser CD; Clunie SK; Towbin JA; Sinagra G; Vatta M
    J Heart Lung Transplant; 2010 Jan; 29(1):98-104. PubMed ID: 19783184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescence imaging microscopy of cellular markers in ischemic vs non-ischemic cardiomyopathy after left ventricular unloading.
    Bick RJ; Bagwell SH; Jones CE; Poindexter BJ; Buja LM; Youker KA; Grigore A; Clubb F; Radovancevic B; Frazier OH
    J Heart Lung Transplant; 2005 Apr; 24(4):454-61. PubMed ID: 15797748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac fibrosis and cellular hypertrophy decrease the degree of reverse remodeling and improvement in cardiac function during left ventricular assist.
    Saito S; Matsumiya G; Sakaguchi T; Miyagawa S; Yamauchi T; Kuratani T; Sawa Y
    J Heart Lung Transplant; 2010 Jun; 29(6):672-9. PubMed ID: 20188595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.